Wedge Capital Management L L P Amgen Inc Transaction History

Wedge Capital Management L L P

$6.04 Billion
Q1 2024

A detailed history of Wedge Capital Management L L P transactions in Amgen Inc stock. As of the latest transaction made, Wedge Capital Management L L P holds 860 shares of AMGN stock, worth $266,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares

860

Previous 108,528 99.21%

Holding current value

$266,066

Previous $31.3 Million 99.22%

% of portfolio

0.0%

Previous 0.56%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$268.87 - $324.56 $28.9 Million - $34.9 Million	-107,668 Reduced 99.21%	860 $244,000
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $3.36 Million - $3.79 Million	-13,134 Reduced 10.8%	108,528 $31.3 Million
Q3 2023 Oct 13, 2023	SELL	$218.65 - $271.46 $4.56 Million - $5.66 Million	-20,840 Reduced 14.62%	121,662 $32.7 Million
Q2 2023 Jul 17, 2023	SELL	$214.27 - $253.37 $4.34 Million - $5.13 Million	-20,234 Reduced 12.43%	142,502 $31.6 Million
Q1 2023 Apr 11, 2023	BUY	$225.79 - $275.2 $4.78 Million - $5.83 Million	21,174 Added 14.96%	162,736 $39.3 Million

Q4 2022 Jan 17, 2023	SELL	$229.03 - $291.01 $3.49 Million - $4.43 Million	-15,220 Reduced 9.71%	141,562 $37.2 Million
Q3 2022 Oct 13, 2022	BUY	$224.46 - $253.15 $1.66 Million - $1.87 Million	7,395 Added 4.95%	156,782 $35.3 Million
Q2 2022 Jul 11, 2022	BUY	$230.71 - $256.74 $453,114 - $504,237	1,964 Added 1.33%	149,387 $36.3 Million
Q1 2022 Apr 12, 2022	SELL	$219.27 - $242.57 $667,457 - $738,383	-3,044 Reduced 2.02%	147,423 $35.7 Million
Q4 2021 Jan 24, 2022	BUY	$198.88 - $227.6 $921,411 - $1.05 Million	4,633 Added 3.18%	150,467 $33.9 Million
Q3 2021 Oct 14, 2021	BUY	$212.27 - $248.7 $3.03 Million - $3.55 Million	14,282 Added 10.86%	145,834 $31 Million
Q2 2021 Jul 14, 2021	BUY	$233.58 - $259.14 $1.34 Million - $1.48 Million	5,718 Added 4.54%	131,552 $32.1 Million
Q1 2021 Apr 12, 2021	BUY	$221.91 - $258.6 $875,213 - $1.02 Million	3,944 Added 3.24%	125,834 $31.3 Million
Q4 2020 Jan 08, 2021	BUY	$216.38 - $257.67 $2.81 Million - $3.34 Million	12,969 Added 11.91%	121,890 $28 Million
Q3 2020 Oct 08, 2020	SELL	$234.65 - $260.95 $7.93 Million - $8.82 Million	-33,809 Reduced 23.69%	108,921 $27.7 Million
Q2 2020 Jul 10, 2020	BUY	$197.81 - $242.74 $28 Million - $34.4 Million	141,601 Added 12542.16%	142,730 $33.7 Million
Q1 2020 Apr 13, 2020	SELL	$182.24 - $241.7 $31.1 Million - $41.2 Million	-170,639 Reduced 99.34%	1,129 $229,000
Q4 2019 Jan 15, 2020	SELL	$189.21 - $243.2 $756,083 - $971,827	-3,996 Reduced 2.27%	171,768 $41.4 Million
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $30.4 Million - $36.4 Million	174,646 Added 15621.29%	175,764 $34 Million
Q2 2019 Aug 01, 2019	BUY	$166.7 - $195.41 $186,370 - $218,468	1,118 New	1,118 $206,000
Q1 2019 May 02, 2019	SELL	$180.87 - $203.88 $31.2 Million - $35.2 Million	-172,497 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$178.4 - $208.25 $401,043 - $468,146	2,248 Added 1.32%	172,497 $33.6 Million
Q3 2018 Nov 01, 2018	BUY	$185.29 - $208.89 $719,851 - $811,537	3,885 Added 2.34%	170,249 $35.3 Million
Q2 2018 Jul 31, 2018	SELL	$166.05 - $186.51 $4.05 Million - $4.55 Million	-24,396 Reduced 12.79%	166,364 $30.7 Million
Q1 2018 May 01, 2018	SELL	$169.43 - $198.0 $11.6 Million - $13.5 Million	-68,284 Reduced 26.36%	190,760 $32.5 Million
Q4 2017 Jan 31, 2018	BUY	$168.79 - $188.59 $6.41 Million - $7.17 Million	38,005 Added 17.19%	259,044 $45 Million
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $37 Million - $42.2 Million	221,039	221,039 $41.2 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

News

Stay updated on Wedge Capital Management L L P with notifications on news.

Account

Wedge Capital Management L L P Amgen Inc Transaction History